Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults

计划入组 30 人 · 首次发布于 2011 年 10 月 20 日

The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity

计划入组 188 人 · 首次发布于 2012 年 5 月 21 日

Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

计划入组 215 人 · 首次发布于 2021 年 4 月 9 日

nPT-CLN series (Biotica)

FOV-1201

Tacrolimus(Advagraf, Astagraf, Envarsus, Modigraf, Prograf, Protopic, Tacforius)

C₄₄H₆₉NO₁₂ · Rx

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

LifeMine Therapeutics Initiates First-in-Human Trial of Novel Calcineurin Inhibitor LIFE-001

LifeMine Therapeutics Raises $263M to Advance Novel Calcineurin Inhibitor LIFE-001 for Organ Transplant Rejection

Eledon Pharmaceuticals Completes Enrollment in Phase 2 BESTOW Trial of Tegoprubart for Kidney Transplant Rejection